Circulating Tumor Cell Data: Integration with Imaging and Serum Tumor Markers for Metastatic Breast Cancer Patient Management

Publisher： Karger

E-ISSN： 1662-6575|7|1|175-181

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.1, 2014-03, pp. : 175-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 217-221

Karger

Access to resources Recommend Favorite

Use of Serum Tumor Markers for the Diagnosis and Follow-Up of Breast Cancer

By  

Oncology, Vol. 55, Iss. 5, 1998-08 ,pp. : 447-449

Karger

Access to resources Recommend Favorite

Immunomagnetic Tumor Cell Enrichment Is Promising in Detecting Circulating Breast Cancer Cells

By  

Oncology, Vol. 64, Iss. 2, 2003-02 ,pp. : 160-165

Karger

Access to resources Recommend Favorite

Reduction in Circulating Tumor Cell Count following Therapy with nab®-Paclitaxel plus Carboplatin in a Patient with Leptomeningeal Carcinomatosis from Breast Cancer

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-01 ,pp. : 56-61

Karger

Access to resources Recommend Favorite

Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 10, 2015-11 ,pp. : 2513-2519

John Wiley & Sons Inc

Access to resources Recommend Favorite